Dinutuximab Beta
ATC L01FX06 · 6 markets · 7 records
Dinutuximab Beta
Forms
AU 2 records · 2 strengths
- 4.5 mg/mLliquidQARZIBA dinutuximab beta 4.5 mg/mL concentrate for solution for infusion, 20 mg/4.5 mL vial
Records without a stated strength · 1 QARZIBA
GB 1 records · 1 strengths
- 20 mg/4.5 mLinjectionQarziba 20mg/4.5ml concentrate for solution for infusion vials
ES 1 records · 1 strengths
- 4.5 mg/1 mLinjectionQARZIBA
TW 1 records · 1 strengths
- 4.5 mginjectionQarziba 4.5 mg/mL concentrate for solution for infusion寬利安濃縮輸注液
HK 1 records · 1 strengths
Records without a stated strength · 1 QARZIBA CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/4.5ML
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 QARZIBA
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.